1 of 4

Long Story Short Episode 62: Therapeutic Apheresis and Long COVID

Therapeutic Apheresis and Long COVID

This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.

Share this Lesson
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT